机器学习揭示阿片类药物处方指南的适用边界:多机构研究
本研究基于一个机构2017-2018年1867例手术患者的回顾性队列,利用机器学习预测出院后阿片类药物消耗是否超出机构处方指南,并在第二个机构2020-2021年498例患者中外部验证。年龄、BMI、吸烟、术前阿片暴露和院内阿片消耗是最强预测因子,lasso回归模型在开发队列的AUC为0.74(95%CI 0.67-0.81),外部验证AUC为0.67(0.60-0.74),在另一机构指南下AUC为0.76(0.72-0.80)。模型有助于识别适合遵循指南的患者及需要个体化处方的患者。
要点
- 年龄、BMI、吸烟、术前阿片暴露和院内阿片消耗是出院后阿片消耗的最强预测因子。
- lasso回归模型预测出院后阿片消耗的AUC在开发队列为0.74,外部验证为0.67。
- 模型可辅助医生对典型患者遵循指南,对非典型患者个体化处方。
核心结论
- 患者特征可可靠预测出院后阿片消耗相对于处方指南的偏离,模型有助于医生对典型患者遵循指南、对 others 个体化处方。
研究设计与样本
- 回顾性队列研究,开发队列来自一个机构2017-2018年手术患者1867例,外部验证队列来自第二个机构2020-2021年498例患者。
主要发现
- 年龄、BMI、吸烟、术前阿片暴露和院内阿片消耗是出院后消耗的最强预测因子。
- lasso回归模型预测出院后阿片消耗的AUC为0.74(95%CI 0.67-0.81)。
- 有限lasso模型外部验证AUC为0.67(95%CI 0.60-0.74)。
- 在另一机构指南下评估,AUC为0.76(95%CI 0.72-0.80)。
临床怎么用
- 模型可用于帮助医生有信心地对典型阿片反应患者遵循处方指南,并对其他患者进行更个体化的处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many U.S. institutions have adopted postsurgical opioid-prescribing guidelines to standardize prescribing practices, and yet there is inherent variability in patients' opioid consumption after surgery. The utility of these guidelines is limited by the fact that some patients' needs will inevitably exceed them, and yet there are no evidence-based tools to help providers identify these patients. In this study we aimed to maximize the value of these guidelines by training machine learning models to predict patients whose needs will be met by these smaller recommended prescriptions, and patients who may require an additional degree of personalization. The aim of the present study was to develop predictive models for determining whether a surgical patient's postdischarge opioid requirement will fall above or below common opioid prescribing guidelines. METHODS: We conducted a retrospective cohort study of surgical patients at one institution from 2017 to 2018. Patients were called after discharge to collect opioid consumption data. Machine learning models were used to identify outlier opioid consumers (ie, exceeding our institutional prescribing guidelines) using diagnosis codes, medical history, in-hospital opioid use, and perioperative factors as predictors. External validation was performed on opioid consumption data collected at a second institution from 2020 to 2021, and sensitivity analysis was performed using a third institution's prescribing guidelines. RESULTS: The development and external validation cohorts included 1,867 and 498 patients, respectively. Age, body mass index, tobacco use, preoperative opioid exposure, and in-hospital opioid consumption were the strongest predictors of postdischarge consumption. A lasso regression model exhibited an area under the receiver operating characteristic curve of 0.74 (95% confidence interval 0.67-0.81) in predicting postdischarge opioid consumption. External validation of a limited lasso model yielded an area under the receiver operating characteristic curve of 0.67 (0.60-0.74). Performance was preserved when evaluated on another institution's guidelines (area under the receiver operating characteristic curve 0.76 [0.72-0.80]). CONCLUSION: Patient characteristics reliably predict postdischarge opioid consumption in relation to prescribing guidelines for both opioid-naive and exposed populations. This model may be used to help providers confidently follow prescribing guidelines for patients with typical opioid responsiveness and correctly pursue more personalized prescribing for others.
引用
- Yu JK, Marwaha JS, Kennedy CJ, et al. Who doesn't fit? A multi-institutional study using machine learning to uncover the limits of opioid prescribing guidelines. Surgery. 2022. PMID: 35527053. doi:10.1016/j.surg.2022.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。